Optimizing outcomes in gastrointestinal stromal tumors: A surgeon's perspective
Last Updated: Tuesday, December 17, 2024
This case of a 54-year-old male with abdominal pain and weight loss who was diagnosed with a high-grade gastrointestinal stromal tumor (GIST) highlights GIST management through tyrosine kinase inhibitors, surgical intervention, risk stratification, and emerging therapies targeting KIT and PDGFRA mutations to improve outcomes. Treatment included imatinib, surgical resection, and follow-up monitoring.
Advertisement
News & Literature Highlights